DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Risperdal Consta (Risperidone) - Drug Ineffective - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Drug Ineffective (35)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Risperdal Consta (Risperidone) where reactions include drug ineffective. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 35   Next >>

Possible Risperdal Consta side effects in male

Reported by a consumer/non-health professional from United States on 2012-08-06

Patient: male

Reactions: Movement Disorder, Weight Decreased, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Injury, Depression, Muscle Spasms, Back Pain, Inappropriate Schedule of Drug Administration, Dysphagia, Dystonia, Grimacing, Condition Aggravated, Abnormal Behaviour, Torticollis, Muscle Twitching, Dissociation, Suicide Attempt, Disturbance in Attention, Tardive Dyskinesia, Extrapyramidal Disorder, Gait Disturbance, Hypertension

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Dosage: ndc 050468-306
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Invega
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2008-05-01
    End date: 2009-11-01

Risperdal
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-07-07
    End date: 2011-02-02

Cogentin
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-12-11

Risperdal Consta
    Indication: Major Depression
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Zyprexa
    Indication: Schizophrenia

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Indication: Bipolar Disorder
    Start date: 2009-01-01

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01



Possible Risperdal Consta side effects in male

Reported by a consumer/non-health professional from Norway on 2012-07-20

Patient: male

Reactions: Hospitalisation, Drug Ineffective, Coma, Feeling Abnormal, Verbal Abuse

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Risperdal Consta
    Dosage: since some years
    Indication: Product Used FOR Unknown Indication

Risperdal Consta
    Dosage: dose decreased about 2 years before this report

Risperdal Consta
    Dosage: dose decreased about 6 months before this report

Other drugs received by patient: Abilify



Possible Risperdal Consta side effects in male

Reported by a consumer/non-health professional from United States on 2012-07-03

Patient: male

Reactions: Weight Decreased, Movement Disorder, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Injury, Depression, Muscle Spasms, Back Pain, Inappropriate Schedule of Drug Administration, Dysphagia, Grimacing, Dystonia, Condition Aggravated, Abnormal Behaviour, Torticollis, Muscle Twitching, Dissociation, Disturbance in Attention, Suicide Attempt, Tardive Dyskinesia, Gait Disturbance, Extrapyramidal Disorder, Hypertension

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Cogentin
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-12-11

Risperdal Consta
    Indication: Bipolar Disorder
    Start date: 2009-01-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Invega
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2008-05-01
    End date: 2009-11-01

Risperdal
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-07-07
    End date: 2011-02-02

Zyprexa
    Indication: Schizophrenia

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Indication: Major Depression
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Dosage: ndc 050468-306
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-04-07
    End date: 2011-02-02



Possible Risperdal Consta side effects in 36 year old male

Reported by a physician from Switzerland on 2012-07-02

Patient: 36 year old male

Reactions: Drug Ineffective, Psoriasis

Drug(s) suspected as cause:
Risperdal Consta



Possible Risperdal Consta side effects in 39 year old female

Reported by a consumer/non-health professional from Turkey on 2012-07-02

Patient: 39 year old female

Reactions: Chest Discomfort, Angina Pectoris, Drug Ineffective

Drug(s) suspected as cause:
Risperdal Consta



Possible Risperdal Consta side effects in male

Reported by a physician from Philippines on 2012-06-26

Patient: male

Reactions: Drug Ineffective, Hypoglycaemia, Urinary Incontinence, Intentional Drug Misuse, Throat Tightness

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Invega
    Administration route: Oral
    Indication: Schizophrenia
    End date: 2012-06-11

Invega Sustenna
    Indication: Schizophrenia
    Start date: 2012-06-11

Risperdal Consta
    Indication: Schizophrenia
    End date: 2012-06-11

Glipizide
    Dosage: 4 tablets per meal
    Indication: Product Used FOR Unknown Indication



Possible Risperdal Consta side effects in male

Reported by a physician from United States on 2012-06-26

Patient: male

Reactions: Weight Decreased, Movement Disorder, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Injury, Depression, Muscle Spasms, Back Pain, Inappropriate Schedule of Drug Administration, Dysphagia, Grimacing, Dystonia, Abnormal Behaviour, Condition Aggravated, Torticollis, Muscle Twitching, Dissociation, Suicide Attempt, Disturbance in Attention, Gait Disturbance, Extrapyramidal Disorder, Tardive Dyskinesia, Hypertension

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-07-07
    End date: 2011-02-02

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Start date: 2009-01-01

Cogentin
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-12-11

Risperdal Consta
    Indication: Major Depression
    Start date: 2010-04-01
    End date: 2010-08-01

Invega
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2008-05-01
    End date: 2009-11-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Dosage: ndc 050468-306
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Zyprexa
    Indication: Schizophrenia

Risperdal Consta
    Indication: Bipolar Disorder
    Start date: 2009-01-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01



Possible Risperdal Consta side effects in male

Reported by a physician from United States on 2012-06-05

Patient: male

Reactions: Movement Disorder, Weight Decreased, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Depression, Injury, Muscle Spasms, Inappropriate Schedule of Drug Administration, Back Pain, Dysphagia, Dystonia, Grimacing, Condition Aggravated, Abnormal Behaviour, Torticollis, Muscle Twitching, Dissociation, Gait Disturbance, Extrapyramidal Disorder, Tardive Dyskinesia, Hypertension

Drug(s) suspected as cause:
Invega
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2008-05-01
    End date: 2009-11-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-07-07
    End date: 2011-02-02

Cogentin
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-12-11

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Indication: Bipolar Disorder
    Start date: 2009-01-01

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Dosage: ndc 050468-306
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Indication: Major Depression
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Zyprexa
    Indication: Schizophrenia



Possible Risperdal Consta side effects in male

Reported by a physician from United States on 2012-05-31

Patient: male

Reactions: Movement Disorder, Weight Decreased, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Depression, Muscle Spasms, Back Pain, Inappropriate Schedule of Drug Administration, Dysphagia, Grimacing, Dystonia, Condition Aggravated, Abnormal Behaviour, Torticollis, Muscle Twitching, Dissociation, Gait Disturbance, Tardive Dyskinesia, Extrapyramidal Disorder, Hypertension

Drug(s) suspected as cause:
Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-07-07
    End date: 2011-02-02

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Invega
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2008-05-01
    End date: 2009-11-01

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Start date: 2009-01-01

Zyprexa
    Indication: Schizophrenia

Risperdal Consta
    Indication: Major Depression
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Indication: Bipolar Disorder
    Start date: 2009-01-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Cogentin
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-12-11

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Dosage: ndc 050468-306
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-04-07
    End date: 2011-02-02



Possible Risperdal Consta side effects in female

Reported by a health professional (non-physician/pharmacist) from Australia on 2012-05-29

Patient: female

Reactions: Drug Ineffective, Encephalitis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Risperdal Consta

Risperdal Consta
    Indication: Schizophrenia



Possible Risperdal Consta side effects in male

Reported by a consumer/non-health professional from United States on 2012-05-15

Patient: male

Reactions: Weight Decreased, Movement Disorder, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Depression, Muscle Spasms, Back Pain, Inappropriate Schedule of Drug Administration, Dysphagia, Dystonia, Grimacing, Abnormal Behaviour, Condition Aggravated, Torticollis, Muscle Twitching, Dissociation, Gait Disturbance, Tardive Dyskinesia, Extrapyramidal Disorder, Hypertension

Drug(s) suspected as cause:
Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Indication: Major Depression
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Invega
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2008-05-01
    End date: 2009-11-01

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Zyprexa
    Indication: Schizophrenia

Cogentin
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-12-11

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Dosage: ndc 050468-306
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Indication: Bipolar Disorder
    Start date: 2009-01-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-07-07
    End date: 2011-02-02



Possible Risperdal Consta side effects in female

Reported by a physician from Norway on 2012-05-08

Patient: female

Reactions: Restlessness, Drug Ineffective, Parkinsonism, Migraine With Aura, Blood Prolactin Increased, Visual Impairment, Blood Cholesterol Increased, Tardive Dyskinesia, Tension, Latent Autoimmune Diabetes in Adults

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cisordinol
    Indication: Schizophrenia, Paranoid Type
    Start date: 1994-01-01

Trilafon
    Dosage: 108 mg/ml

Trilafon
    Indication: Schizophrenia, Paranoid Type

Seroquel
    Indication: Schizophrenia, Paranoid Type
    Start date: 2003-07-01

Risperdal
    Indication: Schizophrenia, Paranoid Type

Trilafon
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 1993-01-01
    End date: 1994-01-01

Risperdal Consta
    Indication: Schizophrenia, Paranoid Type
    Start date: 2003-05-30
    End date: 2003-07-21

Risperdal
    Start date: 2003-05-30
    End date: 2003-07-21



Possible Risperdal Consta side effects in male

Reported by a physician from China on 2012-05-02

Patient: male

Reactions: Drug Ineffective, Suspiciousness, Abnormal Behaviour, Delusion

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Risperdal Consta

Risperdal Consta
    Start date: 2011-03-26
    End date: 2011-03-31

Risperidone
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Risperdal Consta
    Indication: Schizophrenia

Sertraline Hydrochloride
    Administration route: Oral
    Indication: Depression



Possible Risperdal Consta side effects in male

Reported by a consumer/non-health professional from United States on 2012-04-27

Patient: male

Reactions: Weight Decreased, Movement Disorder, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Depression, Muscle Spasms, Inappropriate Schedule of Drug Administration, Back Pain, Dysphagia, Dystonia, Grimacing, Abnormal Behaviour, Condition Aggravated, Torticollis, Muscle Twitching, Dissociation, Extrapyramidal Disorder, Gait Disturbance, Tardive Dyskinesia, Hypertension

Drug(s) suspected as cause:
Risperdal Consta
    Indication: Major Depression
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Indication: Bipolar Disorder
    Start date: 2009-01-01

Risperdal Consta
    Dosage: ndc 050468-306
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-04-07
    End date: 2011-02-02

Invega
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2008-05-01
    End date: 2009-11-01

Zyprexa
    Indication: Schizophrenia

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-07-07
    End date: 2011-02-02

Cogentin
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-12-11

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02



Possible Risperdal Consta side effects in male

Reported by a consumer/non-health professional from United States on 2012-04-23

Patient: male

Reactions: Cataract, Drug Ineffective, Adverse Drug Reaction, Squamous Cell Carcinoma of Skin

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Risperdal
    Dosage: began 15 years ago on an unspecified date in 1997

Chlorpromazine
    Indication: Hallucination

Risperdal
    Start date: 2011-01-01

Risperdal Consta
    Indication: Product Used FOR Unknown Indication

Invega
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2005-01-01
    End date: 2011-01-01

Risperdal
    Dosage: began 15 years ago on an unspecified date in 1997
    Indication: Hallucination

Risperdal Consta

Chlorpromazine
    Indication: Schizophrenia

Risperdal
    Start date: 2011-01-01

Risperdal
    Indication: Schizophrenia
    Start date: 2011-01-01

Risperdal
    Dosage: began 15 years ago on an unspecified date in 1997
    Indication: Autism

Other drugs received by patient: Levothyroxine Sodium; Depakote; Diphenhydramine HCL; Fluvoxamine Maleate; Paxil; Benztropine Mesylate; Benztropine Mesylate; Lorazepam



Possible Risperdal Consta side effects in male

Reported by a consumer/non-health professional from United States on 2012-04-05

Patient: male

Reactions: Movement Disorder, Weight Decreased, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Depression, Muscle Spasms, Back Pain, Inappropriate Schedule of Drug Administration, Dysphagia, Grimacing, Dystonia, Condition Aggravated, Abnormal Behaviour, Torticollis, Muscle Twitching, Dissociation, Gait Disturbance, Extrapyramidal Disorder, Tardive Dyskinesia, Hypertension

Drug(s) suspected as cause:
Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Indication: Bipolar Disorder
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-07-07
    End date: 2011-02-02

Risperdal Consta
    Dosage: ndc 050468-306
    Start date: 2010-04-07
    End date: 2011-02-02

Risperdal Consta
    Start date: 2009-01-01

Invega
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2008-05-01
    End date: 2009-11-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Indication: Major Depression
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Zyprexa
    Indication: Schizophrenia

Cogentin
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-12-11

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01



Possible Risperdal Consta side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-03

Patient: male

Reactions: Negative Thoughts, Drug Ineffective, Insomnia, Gastrooesophageal Reflux Disease

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Risperdal Consta
    Indication: Schizoaffective Disorder
    Start date: 2012-02-01
    End date: 2012-02-01

Invega Sustenna
    Indication: Schizoaffective Disorder
    Start date: 2012-03-01

Topamax
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Other drugs received by patient: Depakote; Depakote; Cogentin



Possible Risperdal Consta side effects in male

Reported by a consumer/non-health professional from United States on 2012-03-23

Patient: male, weighing 95.3 kg (209.6 pounds)

Reactions: Weight Decreased, Movement Disorder, Drug Ineffective, Pain, Muscle Tightness, Neck Pain, Musculoskeletal Disorder, Adverse Event, Depression, Muscle Spasms, Back Pain, Inappropriate Schedule of Drug Administration, Dysphagia, Dystonia, Grimacing, Abnormal Behaviour, Condition Aggravated, Torticollis, Muscle Twitching, Dissociation, Gait Disturbance, Tardive Dyskinesia, Hypertension

Drug(s) suspected as cause:
Risperdal Consta
    Dosage: every 4 to 6 weeks
    Indication: Bipolar Disorder
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Indication: Major Depression
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Dosage: every 4 to 6 weeks
    Indication: Schizophrenia, Paranoid Type
    Start date: 2010-01-01
    End date: 2010-01-01

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Start date: 2009-01-01

Zyprexa
    Indication: Schizophrenia

Cogentin
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-12-11

Risperdal Consta
    Dosage: ndc 050468-306

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Dosage: ndc 050468-306

Risperdal Consta
    Start date: 2010-04-01
    End date: 2010-08-01

Invega
    Administration route: Oral
    Indication: Schizophrenia, Paranoid Type
    Start date: 2008-05-01
    End date: 2009-11-01

Risperdal Consta
    Dosage: ndc 050468-306

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01

Risperdal Consta
    Start date: 2009-01-01

Risperdal Consta
    Start date: 2010-05-01
    End date: 2010-10-01



Possible Risperdal Consta side effects in

Reported by a pharmacist from United States on 2012-03-14

Patient:

Reactions: Drug Ineffective, Condition Aggravated

Drug(s) suspected as cause:
Risperdal Consta

Invega Sustenna
    Indication: Product Used FOR Unknown Indication

Risperdal Consta
    Indication: Product Used FOR Unknown Indication



Possible Risperdal Consta side effects in 40 year old male

Reported by a consumer/non-health professional from United Kingdom on 2012-02-27

Patient: 40 year old male

Reactions: Drug Ineffective, Suicide Attempt, Pulmonary Embolism, Suicidal Ideation

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Risperdal Consta



Possible Risperdal Consta side effects in female

Reported by a consumer/non-health professional from France on 2012-02-07

Patient: female

Reactions: Incoherent, Road Traffic Accident, Drug Ineffective, Feeling Abnormal

Drug(s) suspected as cause:
Risperdal Consta

Other drugs received by patient: Tegretol; Zyprexa; Haldol; Risperdal; Zolpidem; Tranxene; TOP MAG; Risperdal; Risperdal



Possible Risperdal Consta side effects in 21 year old male

Reported by a physician from France on 2012-01-27

Patient: 21 year old male

Reactions: Drug Ineffective, Suicidal Ideation, Delusion

Drug(s) suspected as cause:
Risperdal Consta

Other drugs received by patient: Lexomil; Valium; Loxapine HCL; Imovane



Possible Risperdal Consta side effects in female

Reported by a consumer/non-health professional from France on 2012-01-27

Patient: female

Reactions: Incoherent, Road Traffic Accident, Drug Ineffective, Feeling Abnormal

Drug(s) suspected as cause:
Risperdal Consta

Other drugs received by patient: Risperdal; Haldol; Zolpidem; Zyprexa; Tegretol; Risperdal; Tranxene; Risperdal; TOP MAG



Possible Risperdal Consta side effects in female

Reported by a consumer/non-health professional from United States on 2012-01-25

Patient: female, weighing 74.8 kg (164.6 pounds)

Reactions: Agitation, Drug Ineffective, Restlessness, Dyskinesia, Hyperhidrosis, Constipation, Myalgia, Speech Disorder, Overdose, Incontinence, Insomnia, Sedation, Skin Odour Abnormal, Musculoskeletal Stiffness, Gait Disturbance

Drug(s) suspected as cause:
Risperdal Consta
    Indication: Schizophrenia
    Start date: 2011-12-18
    End date: 2011-12-30

Risperdal
    Administration route: Oral
    Indication: Schizophrenia
    Start date: 2011-12-18
    End date: 2012-01-19

Invega Sustenna
    Indication: Schizophrenia
    Start date: 2012-01-18



Possible Risperdal Consta side effects in female

Reported by a consumer/non-health professional from United States on 2012-01-13

Patient: female

Reactions: Weight Decreased, Refusal of Treatment by Patient, Contusion, Drug Ineffective, Insomnia, Nervous System Disorder

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Risperdal Consta

Risperdal Consta
    Start date: 2011-05-01

Risperdal Consta
    Indication: Sleep Disorder Therapy

Risperdal Consta
    Indication: Schizophrenia
    Start date: 2011-05-01

Other drugs received by patient: Klonopin; Remeron; Klonopin



Possible Risperdal Consta side effects in male

Reported by a consumer/non-health professional from United States on 2012-01-06

Patient: male, weighing 79.4 kg (174.6 pounds)

Reactions: Restlessness, Nonspecific Reaction, Drug Ineffective, Pain, Rhinorrhoea, Hyperhidrosis, Insomnia, Anger, Staring

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Risperdal Consta
    Indication: Autism
    Start date: 2010-01-01
    End date: 2011-12-28

Risperdal
    Dosage: 1 mg in am and 1 mg in pm
    Administration route: Oral
    Start date: 2002-01-01
    End date: 2003-01-01

Risperdal
    Administration route: Oral
    Start date: 2003-01-01
    End date: 2011-12-28

Risperdal Consta
    Start date: 2011-12-28

Risperdal
    Administration route: Oral
    Indication: Autism
    Start date: 2003-01-01
    End date: 2011-12-28

Risperdal Consta
    Indication: Bipolar Disorder
    Start date: 2010-01-01
    End date: 2011-12-28

Risperdal Consta
    Indication: Schizophrenia
    Start date: 2010-01-01
    End date: 2011-12-28

Risperdal
    Administration route: Oral
    Indication: Bipolar Disorder
    Start date: 2003-01-01
    End date: 2011-12-28

Risperdal Consta
    Start date: 2011-12-28

Risperdal
    Dosage: 1 mg in am and 1 mg in pm
    Administration route: Oral
    Indication: Schizophrenia
    Start date: 2002-01-01
    End date: 2003-01-01

Risperdal
    Dosage: 1 mg in am and 1 mg in pm
    Administration route: Oral
    Start date: 2002-01-01
    End date: 2003-01-01

Risperdal
    Dosage: 1 mg in am and 1 mg in pm
    Administration route: Oral
    Start date: 2002-01-01
    End date: 2003-01-01

Risperdal Consta
    Start date: 2011-12-28

Risperdal Consta
    Indication: Mental Retardation
    Start date: 2010-01-01
    End date: 2011-12-28

Risperdal Consta
    Start date: 2011-12-28

Risperdal
    Administration route: Oral
    Indication: Mental Retardation
    Start date: 2003-01-01
    End date: 2011-12-28

Other drugs received by patient: Sipraktin; Sipraktin



Possible Risperdal Consta side effects in male

Reported by a consumer/non-health professional from United States on 2012-01-03

Patient: male, weighing 79.4 kg (174.6 pounds)

Reactions: Psychotic Disorder, Drug Ineffective, Schizoaffective Disorder, Self Injurious Behaviour

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Risperdal Consta
    Start date: 2009-01-01
    End date: 2010-01-01

Haldol
    Indication: Schizoaffective Disorder
    Start date: 2011-01-01
    End date: 2011-01-01

Risperdal Consta
    Start date: 2011-09-01

Invega Sustenna
    Indication: Schizoaffective Disorder
    Start date: 2010-01-01
    End date: 2011-03-01

Risperdal Consta
    Indication: Schizoaffective Disorder
    Start date: 2011-01-01
    End date: 2011-01-01

Risperdal Consta
    Start date: 2011-03-01
    End date: 2011-09-01

Other drugs received by patient: Risperdal; Buspar; Clozaril; Clozaril; Buspar; Risperdal



Possible Risperdal Consta side effects in male

Reported by a consumer/non-health professional from United States on 2011-12-09

Patient: male, weighing 77.1 kg (169.6 pounds)

Reactions: Drug Ineffective, Aggression, Delusion

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Risperdal Consta
    Start date: 2011-01-01
    End date: 2011-01-01

Invega Sustenna
    Indication: Schizoaffective Disorder
    Start date: 2010-01-01
    End date: 2011-01-01

Risperdal Consta
    Start date: 2006-01-01
    End date: 2010-01-01

Risperdal
    Indication: Schizoaffective Disorder

Risperdal Consta
    Indication: Schizoaffective Disorder
    Start date: 2011-01-01
    End date: 2011-09-01

Risperdal

Risperdal Consta
    Start date: 2011-09-01

Other drugs received by patient: Clozapine; Buspar



Possible Risperdal Consta side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2011-12-07

Patient: male

Reactions: Drug Ineffective

Drug(s) suspected as cause:
Invega Sustenna
    Indication: Product Used FOR Unknown Indication

Risperdal Consta
    Indication: Product Used FOR Unknown Indication

Risperdal Consta



Possible Risperdal Consta side effects in

Reported by a consumer/non-health professional from Canada on 2011-12-06

Patient:

Reactions: Drug Ineffective, Blood Prolactin Decreased

Drug(s) suspected as cause:
Risperdal Consta



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017